Get started
Author

Inés Pérez-Román

Observed names: I. Perez-Roman, Ines Perez-Roman, Inés Pérez Román, Pérez-Román, Inés
Institution: PharmaMar (Spain)
ORCID: 0000-0001-8466-2519
Observed ORCID: 0000-0001-8466-2519
OpenAlex ID: A5037348167
Cost–utility analysis of germline BRCA1/2 testing in women with high-grade epithelial ovarian cancer in Spain
2019 · Carlota Moya-Alarcón, Almudena González-Domínguez, et al. · Clinical & Translational Oncology · 15
Development of a Solid Formulation Containing a Microemulsion of a Novel Artemisia Extract with Nematocidal Activity for Oral Administration
2020 · Ines Perez-Roman, Filip Kiekens, et al. · Pharmaceutics · 10
PDF
Treatment patterns and use of healthcare resources of patients with atherosclerotic cardiovascular disease and hypercholesterolemia and patients with familial hypercholesterolemia in Spain: Protocol of the Reality study
2022 · Vivencio Barrios, Mar Castellanos, et al. · Frontiers in Cardiovascular Medicine · 8
Impact of Remdesivir on the Treatment of COVID-19 During the First Wave in Spain
2021 · Alejandro Soriano, Rocío Montejano, et al. · Advances in Therapy · 4
PDF
Costs of the management of hemophilia A with inhibitors in Spain
2021 · Santiago Bonanad, María Teresa Álvarez, et al. · Global & Regional Health Technology Assessment · 4
PDF
Enhanced Nematocidal Activity of a Novel Artemisia Extract Formulated as a Microemulsion
2019 · Ines Perez-Roman, Juan J. Garcia-Rodriguez, et al. · Natural Product Communications · 4
PDF
Clinical and economic consequences of ozenoxacin vs. other topical antibiotics for the treatment of impetigo: a real-life study in Spain
2022 · Jaime Rodríguez Quintosa, Cintia Cristina Ago, et al. · Global & Regional Health Technology Assessment · 2
PDF
EE289 Costs Associated With the Administration, Postinfusion Monitoring, and Management of Adverse Events (AEs) Related to Novel Drugs for Second-Line (2L+) Treatment of Small-Cell Lung Cancer (SCLC)
2025 · Jesús Gullón Sanz, Inés Pérez Román · Value in Health · 1
Cost savings from prioritization of non-invasive modalities within CAD diagnostic protocols: a systematic review
2025 · Ben Kluge, James Harris, et al. · Journal of Medical Economics · 1
Cost-effectiveness of CMR over MPS-SPECT: a systematic review of recent trends for diagnosing CAD
2025 · Ben Kluge, James Harris, et al. · Journal of Medical Economics
MT65 Systematic Review of the Health-Economic Impact of Diagnostic Modality Selection for Patients with Coronary Artery Disease
2023 · B. Kluge, I. Sanchez, et al. · Value in Health
PDF
Impact of remdesivir for the treatment of COVID-19 during the first wave in Spain
2021 · Alejandro Soriano, Rocío Montejano, et al. · Research Square
PDF
Impacto presupuestario del rescate precoz con surfactante pulmonar porcino en recién nacidos prematuros con Síndrome de Distrés Respiratorio en España
2021 · Míriam Solozabal, Marta López Sanromà, et al. · Economía de la Salud
PDF
Desarrollo galénico de formulaciones de acción antiparasitaria de extractos de Artemisia
2019 · Inés Pérez-Román · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
PDF
Works count: 17
Citation count: 49
H-index: 4
I10-index: 2
Year
Topic
Type